Unique ID issued by UMIN | UMIN000019882 |
---|---|
Receipt number | R000022968 |
Scientific Title | Efficacy of liber function and safety by ingestion of supplement containing freshwater clam extractive: a randomized, double blind, placebo-controlled cross over study |
Date of disclosure of the study information | 2015/11/20 |
Last modified on | 2016/09/01 15:18:35 |
Efficacy of liber function and safety by ingestion of supplement containing freshwater clam extractive: a randomized, double blind, placebo-controlled cross over study
Efficacy of liber function and safety by ingestion of supplement containing freshwater clam extractive
Efficacy of liber function and safety by ingestion of supplement containing freshwater clam extractive: a randomized, double blind, placebo-controlled cross over study
Efficacy of liber function and safety by ingestion of supplement containing freshwater clam extractive
Japan |
Healthy adult
Adult |
Others
NO
This study aims to evaluate improvement effects of liber function and safety by ingestion of supplement containing freshwater clam extractive for consecutively on healthy adult.
Safety,Efficacy
gamma-GTP (before and after ingestion of supplement for 7 days)
subjective evaluation (before and after ingestion of supplement for 7 days), safety (before and after quintuple ingestion for 4 weeks)
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Placebo
3
Prevention
Food |
Intake test sample for 7 days, and take wash out period for 2 week, then intake placebo for 7 days.
Intake placebo for 7 days, and take wash out period for 2 week, then intake test sample for 7 days.
Intake quintuple for 4 weeks.
30 | years-old | <= |
69 | years-old | >= |
Male and Female
Male and female between 30 and 69 years of age
1. Subjects with food allergies
2. Subjects who are pregnant or lactating
3. Subjects who consume medicinal product which may influence the outcome of the study
4.Subjects who consume food which may influence the outcome of the study
5. Subjects who are judged as unsuitable for the study by the investigator for other reasons
50
1st name | |
Middle name | |
Last name | Masatomo Najima |
Japan clinical trial association
N.A.
8F, 5-27-3 sendagaya, shibuyaku, Tokyo
03-6457-4666
info@yakujihou.org
1st name | |
Middle name | |
Last name | Hirohisa Kojima |
Japan clinical trial association
N.A.
8F, 5-27-3 sendagaya, shibuyaku, Tokyo
03-6457-4666
info@yakujihou.org
Japan clinical trial association
Yawata Corporation
Profit organization
NO
2015 | Year | 11 | Month | 20 | Day |
Unpublished
Completed
2015 | Year | 10 | Month | 29 | Day |
2015 | Year | 11 | Month | 20 | Day |
2015 | Year | 11 | Month | 20 | Day |
2016 | Year | 09 | Month | 01 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000022968
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |